Clinical trial
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
NCT00320606 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00320606 |
|---|---|
| Title | Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients |
| Official title | Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients (ITN029ST) |
| Acronym | WISP-R |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Transplant, Liver Transplantation |
| Intervention type | Drug |
| Interventions | Immunosuppression Withdrawal |
| Enrollment | 20 |
| Start date | Jun 5, 2006 |
| Primary completion | Nov 30, 2009 |
| Completion | Mar 13, 2017 |
| First posted | May 3, 2006 |
| Last update posted | Sep 20, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: